Aydoğan Aydoğdu

634 total citations
42 papers, 494 citations indexed

About

Aydoğan Aydoğdu is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Aydoğan Aydoğdu has authored 42 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Reproductive Medicine and 8 papers in Molecular Biology. Recurrent topics in Aydoğan Aydoğdu's work include Hormonal and reproductive studies (14 papers), Hypothalamic control of reproductive hormones (6 papers) and Ovarian function and disorders (5 papers). Aydoğan Aydoğdu is often cited by papers focused on Hormonal and reproductive studies (14 papers), Hypothalamic control of reproductive hormones (6 papers) and Ovarian function and disorders (5 papers). Aydoğan Aydoğdu collaborates with scholars based in Türkiye, Serbia and United States. Aydoğan Aydoğdu's co-authors include Alper Sönmez, Ümit Aydoğan, İlker Taşçı, Abdullah Taşlıpınar, Erol Bolu, Kenan Sağlam, Serkan Tapan, Ömer Azal, Cem Haymana and Ronald S. Swerdloff and has published in prestigious journals such as Clinical Endocrinology, European Journal of Endocrinology and Biological Trace Element Research.

In The Last Decade

Aydoğan Aydoğdu

40 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aydoğan Aydoğdu Türkiye 13 212 134 103 60 57 42 494
M. Lundqvist Sweden 15 153 0.7× 110 0.8× 43 0.4× 55 0.9× 53 0.9× 40 532
Uma Yallampalli United States 16 154 0.7× 174 1.3× 40 0.4× 70 1.2× 44 0.8× 31 646
MarkéŽta Vaňkov‡á Czechia 15 157 0.7× 125 0.9× 211 2.0× 28 0.5× 61 1.1× 48 642
Jennifer L. Kirby United States 14 87 0.4× 113 0.8× 101 1.0× 55 0.9× 78 1.4× 24 529
R. J. Woods United Kingdom 12 143 0.7× 81 0.6× 52 0.5× 92 1.5× 17 0.3× 17 645
R. Medlej Lebanon 11 115 0.5× 143 1.1× 45 0.4× 19 0.3× 21 0.4× 22 426
Anna Klukovits Hungary 11 69 0.3× 104 0.8× 38 0.4× 32 0.5× 26 0.5× 18 341
Marianna Minnetti Italy 14 401 1.9× 90 0.7× 66 0.6× 15 0.3× 28 0.5× 55 661
Jean‐Pierre Max France 14 80 0.4× 84 0.6× 40 0.4× 88 1.5× 52 0.9× 28 653
Madan Lal Khurana India 17 355 1.7× 270 2.0× 277 2.7× 18 0.3× 173 3.0× 39 910

Countries citing papers authored by Aydoğan Aydoğdu

Since Specialization
Citations

This map shows the geographic impact of Aydoğan Aydoğdu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aydoğan Aydoğdu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aydoğan Aydoğdu more than expected).

Fields of papers citing papers by Aydoğan Aydoğdu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aydoğan Aydoğdu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aydoğan Aydoğdu. The network helps show where Aydoğan Aydoğdu may publish in the future.

Co-authorship network of co-authors of Aydoğan Aydoğdu

This figure shows the co-authorship network connecting the top 25 collaborators of Aydoğan Aydoğdu. A scholar is included among the top collaborators of Aydoğan Aydoğdu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aydoğan Aydoğdu. Aydoğan Aydoğdu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Haymana, Cem, Alper Sönmez, Aydoğan Aydoğdu, et al.. (2017). Wpływ testosteronowej terapii zastępczej na stężenia witaminy D i FGF-23 w hipogonadyzmie wrodzonym. Endokrynologia Polska. 68(3). 311–616. 5 indexed citations
4.
Haymana, Cem, et al.. (2017). Assessment of a low ankle brachial index in young males with congenital hypogonadism. 1–1. 1 indexed citations
5.
Aydoğdu, Aydoğan & Ronald S. Swerdloff. (2016). Emerging medication for the treatment of male hypogonadism. Expert Opinion on Emerging Drugs. 21(3). 255–266. 21 indexed citations
6.
Taşçı, İlker, et al.. (2016). Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis. Endocrine Metabolic & Immune Disorders - Drug Targets. 16(1). 32–38. 5 indexed citations
7.
Aydoğan, Ümit, et al.. (2015). Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis. Medical Principles and Practice. 24(4). 369–375. 16 indexed citations
8.
Aydoğdu, Aydoğan, Cem Haymana, Onur Erdem, et al.. (2015). Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism. Biological Trace Element Research. 171(1). 26–32. 2 indexed citations
9.
Aydoğdu, Aydoğan, İlker Taşçı, Ferhat Denız, et al.. (2014). Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 14(3). 234–238. 4 indexed citations
10.
Aydoğan, Ümit, James E. Rohrer, Aydoğan Aydoğdu, et al.. (2014). Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease. The Anatolian Journal of Cardiology. 15(7). 571–576. 5 indexed citations
11.
Taşçı, İlker, Mehmet İlkin Naharcı, Ergün Bozoğlu, et al.. (2013). Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes. Endocrine Metabolic & Immune Disorders - Drug Targets. 13(3). 256–263. 23 indexed citations
12.
Aydoğan, Ümit, et al.. (2013). The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Archives of Pharmacal Research. 44(8). 1–9. 9 indexed citations
13.
Aydoğdu, Aydoğan, İlker Taşçı, Serkan Tapan, et al.. (2012). High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology. 28(9). 722–725. 25 indexed citations
14.
Taşçı, İlker, et al.. (2012). Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 12(8). 684–8. 19 indexed citations
15.
Aydoğan, Ümit, Aydoğan Aydoğdu, Mustafa Aparcı, et al.. (2012). Relationship of cystatin C with coronary artery disease and its severity. Coronary Artery Disease. 24(2). 119–126. 25 indexed citations
16.
Sönmez, Alper, Cem Haymana, Erol Bolu, et al.. (2011). Metabolic syndrome and the effect of testosteron treatment in young men with congenital hypogonadotrophic hypogonadism. 26. 1 indexed citations
17.
Sönmez, Alper, Cem Haymana, Erol Bolu, et al.. (2011). Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. European Journal of Endocrinology. 164(5). 759–764. 30 indexed citations
18.
Aydoğdu, Aydoğan, Gökhan Üçkaya, Abdullah Taşlıpınar, et al.. (2010). Calcaneal spur incidence is increased in patients with type 2 diabetes mellitus. 22. 1 indexed citations
19.
Sönmez, Alper, Gökhan Üçkaya, Selim Kılıç, et al.. (2010). The Accuracy of Home Glucose Meters in Hypoglycemia. Diabetes Technology & Therapeutics. 12(8). 619–626. 17 indexed citations
20.
Özel, Melih, Levent Demırtürk, Aydoğan Aydoğdu, et al.. (2007). Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. International Journal of Clinical Practice. 62(5). 754–761. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Lundqvist Breakdown of academic impact, for papers by Uma Yallampalli Breakdown of academic impact, for papers by MarkéŽta Vaňkov‡á Breakdown of academic impact, for papers by Jennifer L. Kirby Breakdown of academic impact, for papers by R. J. Woods Breakdown of academic impact, for papers by R. Medlej Breakdown of academic impact, for papers by Anna Klukovits Breakdown of academic impact, for papers by Marianna Minnetti Breakdown of academic impact, for papers by Jean‐Pierre Max Breakdown of academic impact, for papers by Madan Lal Khurana
Rankless by CCL
2026